An invalid vocabulary is selected. Please change it in the options.
Title Credits Start date - Expiration date
Evolving Treatment Strategies for Acute Myeloid Leukemia 1.00 12/01/2025 - 12:00am to 11/30/2026 - 11:59pm
Emerging Treatment Strategies for High-Risk Myelodysplastic Syndromes 0.50 12/01/2025 - 12:00am to 11/30/2026 - 11:59pm
Incorporating TKIs in the Treatment of Myelofibrosis 0.50 12/01/2025 - 12:00am to 11/30/2026 - 11:59pm
Integrating New Therapies for the Treatment of Chronic Phase Chronic Myeloid Leukemia 0.50 12/01/2025 - 12:00am to 11/30/2026 - 11:59pm
Role of Allogeneic Transplants in Acute Lymphoblastic Leukemia 0.50 12/01/2025 - 12:00am to 11/30/2026 - 11:59pm
Deploying Novel Therapies for Acute Lymphoblastic Leukemia 1.00 12/01/2025 - 12:00am to 11/30/2026 - 11:59pm
Optimizing Patient Care Coordination Between Academic and Community Settings 1.00 12/01/2025 - 12:00am to 11/30/2026 - 11:59pm
Comprehensive Care for Adult Survivors of Hematologic Malignancies 0.50 12/01/2025 - 12:00am to 11/30/2026 - 11:59pm
Archived NCCN Tumor Boards: Hereditary Gastrointestinal Cancers - Expansion of NCCN Recommendations 1.00 12/06/2025 - 12:00am to 12/01/2026 - 12:00am
NCCN Guidelines® Insights - Soft Tissue Sarcoma, Version 1.2025 1.00 12/10/2025 - 12:00am to 12/10/2026 - 11:59pm
Recorded Presentations from the NCCN 2025 Lung Cancer Congress 12/15/2025 - 12:00am to 11/06/2026 - 11:59pm
Recorded Presentation from Optimizing Patient Outcomes - Smoking Cessation: To Vape or Not to Vape? 1.00 12/18/2025 - 12:00am to 12/09/2026 - 11:59pm
Recorded Presentation from Optimizing Patient Outcomes - The Changing Treatment Paradigm for Mantle Cell Lymphoma: Improving the Prognosis with... 1.00 12/19/2025 - 12:00am to 12/17/2026 - 11:59pm
Steady Progress in Multiple Myeloma: Applying New Data and Updated Guidelines Throughout Treatment 2.00 12/19/2025 - 12:00am to 06/18/2026 - 11:59pm
NCCN Guidelines® Insights - Small Cell Lung Cancer, Version 2.2026 1.00 01/10/2026 - 12:00am to 01/10/2027 - 11:59pm

Pages